A genome is a complete set of DNA contained in a single cell of an organism. Genomics is a branch of genetics that studies the sequencing and interpretation of a living organism’s genome.
Clinical Genomics: Introduction
A genome is a complete set of DNA contained in a single cell of an organism. Genomics is a branch of genetics that studies the sequencing and interpretation of a living organism’s genome. Clinical genomics is the analysis of an organism’s genetic make-up for diagnostic reasons such as cancer prognosis or diagnosis, determining pre-existing causes of a potential disease, and tailoring care regimens to the needs of a patient.
Read Report Overview - https://www.transparencymarketresearch.com/clinical-genomics-market.html
Advancement in molecular biology has revolutionized cancer detection and treatment. Modern disease detection techniques focused on the detection of DNA and RNA have several benefits over conventional methods.
Key Drivers and Restraints of Global Clinical Genomics Market
Continuous innovation in clinical genomics to be major driver
- Clinical genomics innovation has resulted in improved health services and improved treatment options for patients. Genetic screening offers various tools for the detection of genetic diseases, including RT-PCR, microarray sequencing, and next-generation sequencing. Availability of various technologies for disease detection provides several options, depending on the cost of the examination, its capability, and other factors. This is projected to fuel the growth of the global clinical genomics market during the forecast period. Comparative genomic hybridization (CGH), also known as chromosomal microarray analysis (CMA), is a technique for identifying copy number variations.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49362
- CGH is considered a new technology that can be used to identify chromosomal abnormalities as well as solid tumors. Due to advances in workflow and cost efficiency, array comparative genomic hybridization (aCGH) is quickly becoming the preferred CGH technique over other conventional techniques. The technology is expected to replace current conventional banding techniques, which in turn is anticipated to propel the global clinical genomics market. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths globally each year, with 70% of new cancer cases projected to be identified in the next 20 years.
- Each type of cancer requires a different approach to treatment. Hence, demand for clinical genomics is expected to increase during the forecast period, driven by rise in prevalence of cancer and the need for personalized medicine. The clinical genomics industry is still in a nascent stage. This is likely to provide significant opportunities to market players.
Clinical Genomics Market: Segmentation
- In terms of product type, the global clinical genomics market can be classified into instruments, consumables & reagents, and services
- Based on application, the global clinical genomics market can be categorized into diagnostics, newborn screening, genetics, carrier screening, prenatal screening, and others
- In terms of test type, the global clinical genomics market can be segregated into molecular tests, chromosomal tests, and biochemical tests
- Based on end-user, the global clinical genomics market can be divided into hospitals & clinics, government laboratories & research centers, academics & research institutes, and specialized clinics
Request for Analysis of COVID19 Impact on Clinical Genomics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=49362
Asia Pacific Clinical Genomics Market to Grow at a Rapid Pace
- In terms of region, the global clinical genomics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America and Europe are projected to be the leading markets for clinical genomics due to rise in health care spending and increase in awareness and adoption of new diagnostic approaches.
- The clinical genomics market is anticipated to expand rapidly due to changing demographics in developing countries such as China, India, Brazil, and South Africa. These countries’ public and private health care spending is expected to rise, inducing companies to shift attention to these markets.
- In the near future, improvements in health care facilities and government reimbursement schemes in both developed and emerging markets are likely to present opportunities in the global clinical genomics market.
Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=49362
Leading Players Operating in Global Clinical Genomics Market
The global clinical genomics market was highly fragmented in 2018. Key players operating in the global clinical genomics market are:
- Beijing Genomics Institute (BGI)
- Centogene AG
- Clinical Genomics Technologies Pty Ltd.
- Eurofins Scientific SE
- Foundation Medicine, Inc.
- Gene by Gene Ltd.
- GenomeDx Biosciences, Inc.
- Genomic Health, Inc.
- Illumina, Inc.
- Invitae Corporation
- Iverson Genetic Diagnostics, Inc.
- MedGenome
- Myriad Genetics, Inc.
- Natera, Inc.
- NeoGenomics, Inc.
- OPKO Health, Inc.
- Pathgroup
- PerkinElmer, Inc.
- Personalis, Inc.
- Quest Diagnostics Incorporated
- Retrogen, Inc.
- Rosetta Genomics, Ltd.
- Strand Life Sciences Pvt. Ltd.
- Veritas Genetic
Browse more Reports by Transparency Market Research:
Empty Capsules Market: With the proliferation of R&D initiatives, the global empty capsules market is foreseen to witness an exceptional growth rate. Clinical trials conducted toward the encapsulation of new and existing drugs are grabbing eyeballs, and capturing a white space in the market which had previously remained untapped.
Viral Vector & Plasmid DNA Manufacturing Market: Technological advancements, increase in awareness about viral vector-based treatments, and rise in demand for vector-based products for research are the major factors anticipated to drive the global viral vector & plasmid DNA manufacturing market during the forecast period.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/